Chemoinformaics analysis of 2-AMINO-3-OXOPROPANOIC ACID
| Molecular Weight | 103.077 | nRot | 2 |
| Heavy Atom Molecular Weight | 98.037 | nRig | 26 |
| Exact Molecular Weight | 103.027 | nRing | 0 |
| Solubility: LogS | -6.142 | nHRing | 0 |
| Solubility: LogP | 7.815 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 11.85 |
| nHD | 2 | BPOL | 6.18203 |
| QED | 0.387 |
| Synth | 4.56 |
| Natural Product Likeliness | 3.289 |
| NR-PPAR-gamma | 0.094 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.049 |
| Pgp-sub | 0 |
| HIA | 0.03 |
| CACO-2 | -5.034 |
| MDCK | 0.00000676 |
| BBB | 0.749 |
| PPB | 0.997845 |
| VDSS | 1.82 |
| FU | 0.0251997 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.402 |
| CYP2c19-inh | 0.061 |
| CYP2c19-sub | 0.968 |
| CYP2c9-inh | 0.093 |
| CYP2c9-sub | 0.488 |
| CYP2d6-inh | 0.114 |
| CYP2d6-sub | 0.748 |
| CYP3a4-inh | 0.2 |
| CYP3a4-sub | 0.522 |
| CL | 15.308 |
| T12 | 0.009 |
| hERG | 0.004 |
| Ames | 0.018 |
| ROA | 0.095 |
| SkinSen | 0.035 |
| Carcinogencity | 0.017 |
| EI | 0.413 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.567 |
| Antiviral | No |
| Prediction | 0.979667 |